J&J execs fall short of bonus-worthy; Orthofix names new CEO;

 @FierceMedDev: Sundance sees future for companion Dx to measure drug-related suicide risk. Story | Follow @FierceMedDev

 @MarkHFierce: Huge: Navidea's lymph node Dx mapping agent is the first of its kind to gain the FDA's blessing in 30 years. Article | Follow @MarkHFierce

 @DamianFierce: Add "find a new CFO" to Quest Diagnostics' "stop shrinking" checklist. Release | Follow @DamianFierce

> Sluggish 2012 sales for Johnson & Johnson ($JNJ) mean the company's execs didn't get their full bonuses, and CEO Alex Gorsky made just over one-third of what former chief William Weldon hauled in. Article

> Patients implanted with St. Jude Medical's ($STJ) now-recalled Riata leads face a tough decision on risky revision surgeries. Story

> Covidien ($COV) is launching three new, FDA-cleared hernia care products, used in laparoscopic inguinal, ventral and umbilical hernia repair. Release

> Orthofix ($OFIX) has appointed Brad Mason to be its CEO, replacing Robert Vaters, who steered the company through a kickback scandal finally resolved in December. More

> Volcano ($VOLC) has launched its Valet Microcatheter in the U.S. and Europe, touting the device as ideal in complex coronary and peripheral interventional procedures for highly stenosed lesions. Item

> The body produces quite a bit of unused energy in the course of basic function, and researchers are working to harness the surplus to power medical devices. News

> Diagnostics outfit Transgenomic reported a 15% drop in revenue in the fourth quarter, leading to a net loss of $2.3 million. Full results

Biotech News

 @FierceBiotech: From FierceBiomarkers.com: GenoMine test spots three new kidney cancer biomarkers. Story | Follow @FierceBiotech

 @JohnCFierce: FDA proposes to dramatically lower the bar on Alzheimer's drugs. Story | Follow @JohnCFierce

 @RyanMFierce: Mesoblast, developer of stem cell therapy for degenerative spine, landed A$170M. Good for regenerative rx field: Release | Follow @RyanMFierce

> Researchers, biopharma companies protest budget cuts at FDA, NIH. More

> Cytos Biotechnology soars on results of asthma-drug study. Item

> Presidio rebounds with Boehringer hep C cocktail collaboration. News

Pharma News

 @FiercePharma: Free generic Lipitor! Wegmans' pharmacy uses atorvastatin as a loss-leader. Cash price? $67.88. Story | Follow @FiercePharma

 @EricPFierce: Hikma has started up production at NJ plant that got FDA warning letter, while injectables going gangbusters. Article | Follow @EricPFierce

> Pfizer takes Indian patent fight to Capitol Hill. News

> Novartis rolls out iPhone apps for cancer patients. More

> Ex-J&J chief's 2012 pay outclasses Gorsky's by almost 3-to-1. Article

Pharma Manufacturing News

> Drugmakers press Congress on sequestered fees slated for inspections. Story

> Moves to help ease drug shortages undercut Spectrum. Item

> Mitsubishi pushes into India with Neuland API deal. Article

> EU API law has drugmakers there in panic. Report

> Hikma's injectables biz rides competitors' woes to new heights. More

Vaccines News

> Top 5 Vaccine Companies by Revenue - 2012. Special Report

> Experts weigh in on smallpox preparedness. Article

> Vaccines falter in fight against whooping cough. News

> Narcolepsy link raises doubts about next-gen adjuvants. Story

> Experts weigh in on smallpox preparedness. More

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.